SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 5/16/08 Immunosyn Corp 10-Q 3/31/08 5:279K Thelen LLP/FA |
Document/Exhibit Description Pages Size 1: 10-Q Quarterly Report HTML 149K 2: EX-31.1 Certification of Chief Executive Officer HTML 13K 3: EX-31.2 Certification of Chief Financial and Accounting HTML 13K Officer 4: EX-32.1 Certification of Chief Executive Officer HTML 8K 5: EX-32.2 Certification of Chief Financial and Accounting HTML 8K Officer
2.
|
Based
on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this
report;
|
3.
|
Based
on my knowledge, the consolidated financial statements, and other
financial information included in this report, fairly present in all
material respects the financial condition, results of operations and cash
flows of the issuer as of, and for, the periods presented in this
report;
|
4.
|
The
issuer’s other certifying officers and I are responsible for establishing
and maintaining disclosure controls and procedures (as defined in Exchange
Act Rules 13a-15(e) and 15d-15(e)) for the issuer and
have:
|
|
a)
|
Designed
such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure
that material information relating to the issuer, including its
consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being
prepared;
|
|
b)
|
Designed
such internal control over financial reporting, or caused such internal
control over financial reporting to be designed under our supervision, to
provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting
principles;
|
|
c)
|
Evaluated
the effectiveness of the issuer’s disclosure controls and procedures and
presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period covered by
this report based on such evaluation;
and
|
|
d)
|
Disclosed
in this report any change in the issuer’s internal control over financial
reporting that occurred during the issuer’s most recent fiscal quarter
(the issuer’s fourth fiscal quarter in the case of an annual report) that
has materially affected, or is reasonably likely to materially affect, the
issuer’s internal control over financial
reporting.
|
5.
|
The
issuer’s other certifying officer(s) and I have disclosed, based on our
most recent evaluation of internal control over financial reporting, to
the issuer’s auditors and the audit committee of the issuer’s board of
directors (or persons performing the equivalent
functions):
|
|
a)
|
All
significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are
reasonably likely to adversely affect the issuer’s ability to record,
process, summarize and report financial information;
and
|
|
b)
|
Any
fraud, whether or not material, that involves management or other
employees who have a significant role in the issuer’s internal control
over financial reporting.
|
Date: May
15,
2008
|
||
Douglas
A. McClain Jr.
Chief
Financial and Accounting Officer
|